SEATTLE--(BUSINESS WIRE)--July 6, 2006--Pacific Biometrics, Inc. (OTCBB: PBME; "PBI") has been awarded a contract with a top multinational pharmaceutical company (the "Sponsor") to provide essential laboratory data for a Phase IIIb cardiovascular trial. This study is part of a major drug-development program to evaluate the prevention and treatment of dyslipidemia, atherosclerosis, and coronary heart disease.
